Alcohol Based Disinfectants Market Analysis

Product Type (Methyl Alcohol, Ethyl Alcohol, Isopropyl Alcohol, N-propyl Alcohol)

The global market of alcohol based disinfectants is segmented and analyzed for demand and supply by product type into methyl alcohol, ethyl alcohol, isopropyl alcohol, and N-propyl alcohol. Out of these, the ethyl alcohol segment is estimated to gain the largest market share of about 28% in the year 2036. The growth of the segment can be attributed to the increasing prevalence of diseases among all age groups. The increasing use of ethyl alcohol for the preparation of disinfectants is rising the market segment growth. The increasing prevalence of infectious diseases such as herpes, influenza virus, vaccinia which are lipophilic and enterovirus, adenovirus, rotavirus, and rhinovirus which include under hydrophilic viruses are estimated to drive the market segment growth. The ethyl alcohol disinfectant can act as a virucidal agent for both hydrophilic and lipophilic viral agents driving the market segment growth. The number of people who suffered from flu in the U.S. during 2010-2020 as per the Centers for Disease Control and Prevention was between 9 million to 41 million with hospitalization of more than 140,000 to 710,000 people and resulted in 12,000 to 52,000 deaths per year.

End-user (Hospitals & Clinics, Households, Residential Washrooms, Industrial Bodies, Research Labs)

The market is also segmented and analyzed for demand and supply by end-user into hospitals & clinics, households, residential washrooms, industrial bodies, research labs, and others. Amongst these segments, the hospitals & clinics segment is expected to garner a significant share of around 29% in the year 2036. Patients suffering from various diseases or disorders often visit hospitals for treatment, and it is necessary to disinfect the area or beds used by the infected patient. Also, the medical staff, nurses, and other personnel, and types of equipment have to be disinfected to prevent the spread of infection.  The increasing clinical trials on humans for the discovery of vaccines, and other drugs during COVID-19 to decrease the deaths and rising research and development to discover the cure for such pandemic diseases are estimated to propel the market segment growth.

Our in-depth analysis of the global market includes the following segments: